- Phone
-
Address
Building A, 27th Floor, Huadu Building, 838 Zhangyang Road, Pudong New Area, Shanghai
Avito (Shanghai) Pharmaceutical Technology Co., Ltd
Building A, 27th Floor, Huadu Building, 838 Zhangyang Road, Pudong New Area, Shanghai
Product namePotassium sucrose octasulfateO11001
English name: Potassium Sucrose Octasulfate
CAS number 73264-44-5
Molecular formula C12H14K8O35S8
Molecular weight 1287.52
Appearance: White solid powder
Purity 99.8%
Content 100.7%
溶解性≥100 mg/mL (H2O)
Melting point>230 ℃
During the drug development process, many different formulations of anionic drug encapsulating solutions were screened. Research has found that sucrose octasulfate is a good anionic drug embedding solution. Sucrose octasulfate is added to the finished product production process and reacts to produce triethylammonium sucrose octasulfate (TEA-SOS). Compared with other formulations, this formulation maintains encapsulation efficiency and has a higher retention rate of irinotecan in liposomes.
Potassium sucrose octasulfate(K-SOS) [CDE registration number: F20210000349; AVT item number: 011001, pharmaceutical injection grade, GMP production, bulk stock supply] is a new type of excipient used as raw material to prepare triethylammonium sucrose octasulfate (TEA-SOS) for liposome drug delivery. Sucrose octasulfate is converted to TEA-SOS through ion exchange. TEA-SOS and lipids are passively encapsulated by polycarbonate membrane compression to form liposomes. Subsequently, TEA-SOS outside the liposomes was removed by filtration, forming an electrochemical gradient across the lipid membrane of the liposomes.
